LDS/Medical Tests/Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants

Usher syndrome type 1F is an autosomal recessive disorder with complete penetrance caused by the presence of a homozygous or a compound heterozygous pathogenic variant in the protocadherin-15 gene (PCDH15) located in chromosome 10q21.1. Single nucleotide variants, large deletions and duplications have been described.

Usher syndrome type 1F is characterized by congenital, bilateral, severe to profound sensorineural hearing loss, adolescent-onset progressive bilateral pigmentary retinopathy, and vestibular dysfunction. This type of hearing loss may benefit from cochlear implants but does not respond to hearing aids.

In general 7-12% of affected individuals with Usher syndrome type 1 are due to the presence of genetic alterations in the PCDH15 gene (USH1F). Usher syndrome type 1F is more common in the Ashkenazi Jewish population, with a carrier frequency of approximately 1 in 141, where the founder variant (c.733C>T, p.Arg245Ter) has been observed in up to 2.48% of this ethnic group.

  • Confirm or stablish the diagnosis of Usher syndrome for symptomatic patients
  • Carrier test for parents or at-risk relatives of affected individual
  • Prenatal and preimplantation genetic diagnosis for at-risk pregnancies if a pathogenic variant has been identified in the family
  • Homozygous or compound heterozygous for PCDH15 gene variant confirms the diagnosis of Usher syndrome type 1F
  • Heterozygous for PCDH15 gene variant in an asymptomatic person confirms a carrier status
  • Homozygous wild type PCDH15 gene does not exclude the possibility of Usher syndrome, or positive carrier status

No pathogenic variants (mutations) were detected

Sequence analysis of selected exons or of the entire coding region by dedeoxi-sequencing or Next Generation Sequencing (NGS), Targeted variant analysis (p.Arg245Ter), Deletion/duplication analysis by quantitative Polymerase Chain Reaction (qPCR), long-range PCR, multiplex ligation-dependent probe amplification (MLPA).

Whole blood collected in EDTA (purple top) or ACD-A (yellow top) tube.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Audiology, Vestibular function, Ophthalmology.

1-2 weeks. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • GeneReviews. Pagon RA, Adam MP, Aedinger HH, et al., editors. Seattle (WA).1993-2015.